Bundibugyo Ebola Deaths In Congo Top 700 As Unknown Chains Drive Fastest-Growing Outbreak
Congolese authorities report at least 1,926 infections and 702 deaths from the Bundibugyo Ebola outbreak in eastern Democratic Republic of Congo as of Monday, July 13, 2026, with confirmed cases also in Uganda.[1]
WHO emergencies chief Chikwe Ihekweazu said roughly 80% of new cases in eastern Congo now come from unknown chains of transmission, and many recent deaths occurred in the community without patients reaching health facilities.[1] Treatment capacity in Bunia has expanded to nearly 800 beds and laboratory capacity has grown from one lab to 14 labs, but WHO officials warn the outbreak continues to outpace response efforts.[1] Dozens of health workers at a northeast Congo treatment center briefly struck over unpaid salaries and bonuses before agreeing to resume care if paid within 72 hours, and U.S. health officials said a U.S. citizen working in Congo tested positive for Ebola.[1]
DR Congo's Ministry of Health confirmed a Bundibugyo virus outbreak in Ituri Province on May 15, 2026, and the World Health Organization later declared a public health emergency of international concern.[2] In early July the WHO began clinical trials that enrolled the first patients to test intravenous remdesivir and the two-antibody cocktail MBP-134, with doses donated through international partners and U.S. BARDA backing.[3]
Early coverage emphasized the rising confirmed case and death totals and spread within known outbreak zones, but reporting has shifted as officials warn most new infections now stem from unknown chains—information that complicates contact tracing and containment.[4][1]
The mainstream summary does not address the alarming context of the outbreak's rapid spread, which has been characterized as the fastest-growing Ebola outbreak ever recorded, with a case doubling rate of every 28 days. This critical detail is underscored by social media reports highlighting the outbreak's unprecedented scale, including the assertion that real case numbers could be two to four times higher than reported figures. Furthermore, while the summary mentions the expansion of treatment and laboratory capacity, it fails to convey the significant challenges posed by a lack of approved vaccines or treatments for the Bundibugyo virus, which complicates response efforts and raises concerns about the adequacy of funding for containment measures. The absence of an effective therapeutic response, coupled with the historical case fatality rates of 30% to 50% for Bundibugyo outbreaks, paints a more dire picture than the summary suggests, emphasizing the urgent need for international support and resources to address the crisis effectively.[5]
Show source details & analysis (6 sources)
📊 Relevant Data
Ituri province, one of the worst-hit areas, had an estimated population of 4.4 million as of 2020.
Ituri Province — Wikipedia / Data Commons
Bundibugyo virus outbreaks have historically had case fatality rates of 30% to 50%.
Ebola disease caused by Bundibugyo virus, Democratic Republic of the Congo — WHO
📌 Key Facts
- As of Monday, July 13, 2026, Congolese authorities report at least 1,926 infections and 702 deaths from the Bundibugyo Ebola outbreak, with confirmed cases also in neighboring Uganda (1,926 infections and 702 deaths).
- WHO emergencies chief Chikwe Ihekweazu said on Tuesday, July 14, 2026, that roughly 80% of new Ebola cases in eastern Congo are arising from unknown chains of transmission and that many recent deaths occurred in the community without patients reaching health facilities (Chikwe Ihekweazu).
- The Africa Centre for Disease Control said on Thursday, July 9, 2026, that this is the fastest-growing Ebola outbreak on the African continent (Africa Centre for Disease Control).
- The outbreak has spread across eastern provinces — Ituri, North Kivu and South Kivu — and Congolese authorities reported new suspected cases in Tshopo and Haut-Uele, including two suspected cases in Kisangani (one linked to Ituri’s Nia‑Nia zone, one under investigation) (Tshopo and Haut-Uele provinces).
- Frontline health workers in Ituri issued a 24‑hour notice on July 5 complaining of unpaid benefits, poor supplies and outside teams’ 'arrogance,' and dozens of health workers at a northeast Congo treatment center went on strike July 13 before agreeing to resume care if paid within 72 hours (dozens of health workers).
- Clinical trials have begun: WHO announced on July 2 that the first patients were enrolled in a Bundibugyo treatment trial testing intravenous remdesivir and the two‑antibody cocktail MBP‑134; MBP‑134 — developed with U.S. BARDA support, which owns and donated existing doses — and a separate post‑exposure prophylaxis trial are part of a coordinated WHO–Africa CDC–university–nonprofit effort to repurpose existing antivirals and antibodies (MBP-134).
- Treatment capacity has expanded in Bunia to nearly 800 beds and laboratory capacity has grown from 1 to 14 labs, but WHO officials warn the outbreak "continues to outpace the response efforts" (nearly 800 beds).
📰 Source Timeline (6)
Follow how coverage of this story developed over time
- As of Monday, July 13, 2026, Congolese authorities report at least 1,926 infections and 702 deaths from the Bundibugyo Ebola outbreak across three provinces, with confirmed cases also in neighboring Uganda.
- WHO emergencies chief Chikwe Ihekweazu said on Tuesday, July 14, 2026, that 80% of new Ebola cases in eastern Congo are now arising from unknown chains of transmission and that many recent deaths occurred in the community without patients reaching health facilities.
- Treatment capacity in Bunia has expanded to nearly 800 beds and laboratory capacity from 1 to 14 labs, but Ihekweazu said the outbreak "continues to outpace the response efforts."
- Dozens of health workers at an Ebola treatment center in northeast Congo went on strike over unpaid salaries and bonuses on Monday, July 13, 2026, briefly disrupting access to care before agreeing Tuesday to resume work if paid within 72 hours.
- The U.S. Centers for Disease Control and Prevention said on Saturday, July 11, 2026, that a U.S. citizen working for a humanitarian organization in Congo tested positive for Ebola, without releasing further personal details.
- Congolese authorities declared the outbreak on May 15, 2026, after weeks of undetected transmission, and clinical trials for potential treatments began in Bunia the week before July 15.
- A Congolese government report published late Wednesday, July 8, 2026, raised the Bundibugyo Ebola outbreak death toll in Democratic Republic of Congo to 600, up from more than 500 previously reported.
- The same report said confirmed Ebola cases have reached 1,759 nationwide as of July 8, 2026.
- Congolese authorities reported new suspected cases in Tshopo and Haut-Uele provinces, areas previously unaffected in this outbreak.
- Two suspected cases were reported in Kisangani, Tshopo province; one is epidemiologically linked to Ituri's Nia-Nia health zone, while the other has no apparent geographical connection to known outbreak areas.
- The Africa Centre for Disease Control said on Thursday, July 9, 2026, that this is the fastest-growing Ebola outbreak on the African continent.
- Congolese authorities reiterated that the outbreak, declared May 15, 2026, is caused by the Bundibugyo Ebola virus, which currently has no approved vaccine or treatment, though clinical trials have just begun.
- A Congolese government report published late Wednesday, July 8, 2026, says Congo's current Bundibugyo Ebola outbreak has caused 600 deaths, up from 506 reported earlier.
- The same report raises the nationwide tally of confirmed Ebola cases in this outbreak to 1,759.
- New suspected Ebola cases have been recorded in Tshopo and Haut-Uele provinces, areas previously unaffected in this outbreak.
- Two suspected cases were reported in Kisangani, the capital of Tshopo province; one is epidemiologically linked to the Nia-Nia health zone in Ituri, while the other has no apparent geographical connection to known outbreaks and is under investigation.
- Congolese authorities reiterate that the current outbreak, first officially declared on May 15, 2026, is caused by the Bundibugyo strain of Ebola, which has no approved vaccine or treatment, even as newly launched clinical trials begin.
- The NPR article confirms that on Thursday, July 2, 2026, WHO announced enrollment of the first patients in a Bundibugyo Ebola treatment trial in the Democratic Republic of Congo and Uganda, specifying that the trial is testing intravenous remdesivir and the monoclonal antibody cocktail MBP-134 against Bundibugyo virus disease.
- It details that MBP-134 is a two-antibody cocktail derived from a survivor of the 2014-2016 West African Ebola (Zaire) outbreak and cites lab data suggesting potential cross-reactivity against the Bundibugyo species.
- The story reports that BARDA, a U.S. HHS agency, funded MBP-134’s development, technically owns the existing doses, and has donated the required quantities for the outbreak trial, according to WHO research lead Vasee Moorthy.
- It adds that a separate trial is slated to begin as soon as this week to test another drug as post-exposure prophylaxis for people recently exposed to Bundibugyo virus.
- Researchers and Africa CDC officials emphasize that the three linked trials form a coordinated WHO–Africa CDC–university–nonprofit effort to repurpose existing antivirals and antibodies because designing new Bundibugyo‑specific agents from scratch would take years.
- By Sunday night, July 5, 2026, Congo's Ministry of Health reported 1,561 confirmed Bundibugyo Ebola cases and 506 deaths since the outbreak was declared on May 15, 2026.
- Frontline workers in Ituri province, the epicenter of the outbreak, issued a 24-hour notice on Sunday, July 5, 2026, threatening to strike over unpaid benefits, inadequate supplies and poor working conditions.
- The workers’ notice complains of poor salaries, lack of adequate equipment, the 'arrogance' of teams sent from Kinshasa, and what they describe as 'excessive' reliance on staff from other provinces instead of hiring locally in Ituri.
- Officials have confirmed the Bundibugyo Ebola outbreak has spread to three eastern provinces: Ituri, North Kivu and South Kivu.
- Authorities have not yet identified a patient zero and estimate that tens of thousands of contacts still need to be traced, and the World Health Organization says the first month of this outbreak was the worst on record for Ebola.